Editorial: Oncogenic PI3KT/Akt/mTOR pathway alterations, ROS homeostasis, targeted cancer therapy and drug resistance

Front Oncol. 2024 Feb 16:14:1372376. doi: 10.3389/fonc.2024.1372376. eCollection 2024.

Authors

Rozangela C Pedrosa¹, Karina B Felipe², Danilo Wilhelm Filho¹

Affiliations

¹ Laboaratory of Experimental Biochemistry, Department of Ecology and Zoology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
² Laboratory of Physiology and Cell Signaling, Department of Clinical Analyses, Federal University of Parana, Curitiba, Parana, Brazil.

No abstract available

Keywords: PI3KT/Akt/mTOR pathway; apoptosis; cancer; cancer therapy; drug resistance.

Publication types

Editorial